Restoril and Haemothorax - a phase IV clinical study of FDA data

Summary:

Haemothorax is reported as a side effect among people who take Restoril (temazepam), especially for people who are 60+ old, also take Xanax, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Haemothorax when taking Restoril. It is created by eHealthMe based on reports of 12,884 people who have side effects when taking Restoril from the FDA, and is updated regularly.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

What is Haemothorax?

Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)) is found to be associated with 417 drugs and 526 conditions by eHealthMe. Check the latest studies of Haemothorax.

On Jul, 19, 2026

12,884 people reported to have side effects when taking Restoril.
Among them, 15 people (0.12%) have Haemothorax.

Among these 15 people:

What is the age of people who have Haemothorax when taking Restoril? *

What are other drugs people take besides Restoril? *

What are other side effects people have besides Haemothorax? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 40.00%
Acute Kidney Failure: 6 people, 40.00%
Pain: 5 people, 33.33%
Atelectasis (partial or complete collapse of the lung): 4 people, 26.67%
Weakness: 4 people, 26.67%
Pleural Effusion (water on the lungs): 4 people, 26.67%
Hypotension (abnormally low blood pressure): 4 people, 26.67%
High Blood Pressure: 4 people, 26.67%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 20.00%
Cardiac Failure Congestive: 3 people, 20.00%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 33.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 26.67%
High Blood Pressure: 4 people, 26.67%
High Blood Cholesterol: 4 people, 26.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 26.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 26.67%
Colitis Ischaemic (due to infection of intestine impaired blood supply to colon): 4 people, 26.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 26.67%
Stress And Anxiety: 2 people, 13.33%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Restoril and have Haemothorax?

- Check whether Haemothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Restoril:

Restoril (13,522 reports)

Haemothorax treatments and more:

Haemothorax (3,670 reports)

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemothorax:

Haemothorax (417 drugs)

Browse all the conditions that are associated with Haemothorax:

Haemothorax (526 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Restoril) and Restoril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.